Clinical Trials on Atrial Fibrillation/Flutter in Patients With High Risk of Stroke in Belgium

Total 3 results

AstraZeneca

Terminated

Long Term Open Follow-up With H376/95 vs. Warfarin

Stroke Prevention in Patients With Atrial Fibrillation

Sweden, Norway, Poland, United Kingdom, Finland, Denmark, United States, Czech Republic, Belgium
Diakron Pharmaceuticals
Drug Research Unit Ghent, Ghent, Belgium; Kinesis Pharma B.V.

Terminated

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

Deep Vein Thrombosis Leg | Stroke (in Patients With Atrial Fibrillation)

Belgium
Boston Scientific Corporation

Completed

Registry on WATCHMAN Outcomes in Real-Life Utilization (EWOLUTION)

Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke

Ireland, Spain, Germany, Netherlands, France, United Kingdom, Italy, Russian Federation, Portugal, Belgium, Poland, Saudi Arabia, United Arab Emirates

3

Subscribe